US Stock MarketDetailed Quotes

NKTR Nektar Therapeutics

Watchlist
  • 0.8920
  • +0.0003+0.03%
Close Jan 17 16:00 ET
  • 0.8920
  • 0.00000.00%
Post 20:01 ET
164.54MMarket Cap-1.06P/E (TTM)

Nektar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Nektar Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 22.390M--
--2024/Q4-- / 36.654M--
Nov 7, 20242024/Q324.124M / 18.280M--
Aug 8, 20242024/Q223.489M / 17.545M--
May 9, 20242024/Q121.639M / 15.342M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 22.390M--
--2024/Q4-- / 36.654M--
Nov 7, 20242024/Q324.124M / 18.280M--
Aug 8, 20242024/Q223.489M / 17.545M--
May 9, 20242024/Q121.639M / 15.342M--

Unlock Free Earnings Estimates

Nektar Therapeutics Earnings Reports

  • Nektar Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 8, 2024 12:20 ET

  • Nektar Therapeutics | 8-K: Nektar Therapeutics Reports Third Quarter 2024 Financial Results

    Nov 7, 2024 16:39 ET

  • Nektar Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 9, 2024 14:07 ET

  • Nektar Therapeutics | 8-K: Nektar Therapeutics Reports Second Quarter 2024 Financial Results

    Aug 8, 2024 16:27 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 11, 2025

    Strong Buy

    • Buy

      80.00%

    • Hold

      20.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data